<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Liu HN</submitter><funding>NIAID NIH HHS</funding><funding>NLM NIH HHS</funding><pubmed_abstract>&lt;h4>Background &amp; aims&lt;/h4>Integrated HBV DNA (iDNA) plays a critical role in HBV pathogenesis, particularly in predicting treatment response and HCC. This study aimed to use an HBV hybridization-capture next-generation sequencing (HBV-NGS) assay to detect HBV-host junction sequences (HBV-JS) in a sensitive nonbiased manner to detect and estimate the iDNA fraction in tissue biopsies and HBV genetics by liquid biopsy.&lt;h4>Methods&lt;/h4>HBV DNA from plasmid monomers, HBV-HCC cell line (SNU398, Hep3B, and PLC/PRF/5), tissue biopsies of patients with serum HBV DNA &lt;4 log IU/ml, and matched urine and plasma of HBV patients were assessed by HBV-NGS. Junction-specific qPCR (JS-qPCR) assays were developed to quantify abundant HBV-JS.&lt;h4>Results&lt;/h4>We demonstrated high coverage uniformity, reproducibi</pubmed_abstract><journal>medRxiv : the preprint server for health sciences</journal><pagination>2024.12.04.24318256</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11643158</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Integrated DNA estimation in tissue biopsy and detection in liquid biopsy by HBV-targeted NGS assay.</pubmed_title><pmcid>PMC11643158</pmcid><funding_grant_id>T15 LM007059</funding_grant_id><funding_grant_id>R43 AI167169</funding_grant_id><funding_grant_id>R56 AI179574</funding_grant_id><funding_grant_id>R43 AI174349</funding_grant_id><pubmed_authors>Liu HN</pubmed_authors><pubmed_authors>Shieh FS</pubmed_authors><pubmed_authors>Ramirez R</pubmed_authors><pubmed_authors>Kim ES</pubmed_authors><pubmed_authors>Su YH</pubmed_authors><pubmed_authors>Heimer Z</pubmed_authors><pubmed_authors>Kubas R</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Chang TT</pubmed_authors><pubmed_authors>Lau DTY</pubmed_authors><pubmed_authors>Guo H</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Lin SY</pubmed_authors><pubmed_authors>Chen SE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Integrated DNA estimation in tissue biopsy and detection in liquid biopsy by HBV-targeted NGS assay.</name><description>&lt;h4>Background &amp; aims&lt;/h4>Integrated HBV DNA (iDNA) plays a critical role in HBV pathogenesis, particularly in predicting treatment response and HCC. This study aimed to use an HBV hybridization-capture next-generation sequencing (HBV-NGS) assay to detect HBV-host junction sequences (HBV-JS) in a sensitive nonbiased manner to detect and estimate the iDNA fraction in tissue biopsies and HBV genetics by liquid biopsy.&lt;h4>Methods&lt;/h4>HBV DNA from plasmid monomers, HBV-HCC cell line (SNU398, Hep3B, and PLC/PRF/5), tissue biopsies of patients with serum HBV DNA &lt;4 log IU/ml, and matched urine and plasma of HBV patients were assessed by HBV-NGS. Junction-specific qPCR (JS-qPCR) assays were developed to quantify abundant HBV-JS.&lt;h4>Results&lt;/h4>We demonstrated high coverage uniformity, reproducibi</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2026-05-27T03:16:18.833Z</modification><creation>2025-04-04T21:45:41.071Z</creation></dates><accession>S-EPMC11643158</accession><cross_references><pubmed>39677449</pubmed><doi>10.1101/2024.12.04.24318256</doi></cross_references></HashMap>